GlobeNewswire (press release) ... Dr. Schaible's group designed and conducted the SONIC trial in Crohn's disease, a major clinical trial published in the New England Journal of Medicine, demonstrating the superiority of REMICADE® versus a conventional immunomodulator (azathioprine) ... and more »
GlobeNewswire (press release) ... Dr. Schaible's group designed and conducted the SONIC trial in Crohn's disease, a major clinical trial published in the New England Journal of Medicine, demonstrating the superiority of REMICADE® versus a conventional immunomodulator (azathioprine) ... and more »
Watch List News (press release) New research by scientists at the Vitiligo Research Foundation now shows that established immunomodulator drugs such as Sodium oxodihydroacridinylacetate may be effective in stopping vitiligo, a chronic autoimmune skin disease which affects nearly 100 ...
